News | March 23, 2022
Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Building the future of food in the birthplace of cell-cultured milk
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
According to IQVIA sales data for the period ending January 2022, Vimpat tablets market achieved annual sales of approx. US $ 1.7 billion
Subscribe To Our Newsletter & Stay Updated
